141 related articles for article (PubMed ID: 37977008)
1. Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy.
Chen M; Shen Y; Pu Y; Zhou B; Bing J; Ge M; Zhu Y; Gao S; Wu W; Zhou M; Shi J
Biomaterials; 2023 Dec; 303():122386. PubMed ID: 37977008
[TBL] [Abstract][Full Text] [Related]
2. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
4. A Biomimetic Metal-Organic Framework Nanosystem Modulates Immunosuppressive Tumor Microenvironment Metabolism to Amplify Immunotherapy.
Wang H; Wu C; Tong X; Chen S
J Control Release; 2023 Jan; 353():727-737. PubMed ID: 36473607
[TBL] [Abstract][Full Text] [Related]
5. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation.
Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y
Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328
[TBL] [Abstract][Full Text] [Related]
6. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
8. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
10. A Dihydroartemisinin-Loaded Nanoreactor Motivates Anti-Cancer Immunotherapy by Synergy-Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage.
Li LG; Yang XX; Xu HZ; Yu TT; Li QR; Hu J; Peng XC; Han N; Xu X; Chen NN; Chen X; Tang JM; Li TF
Adv Healthc Mater; 2023 Nov; 12(28):e2301561. PubMed ID: 37567571
[TBL] [Abstract][Full Text] [Related]
11. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
12. Repolarizing tumor-associated macrophages by layered double hydroxide-based deacidification agent for tumor chemodynamic therapy and immunotherapy.
Chen C; Zhang W; Lu SY; Wang J; Tan Y; Zhao S; Ouyang Y; Xu L; Zhou B; Yin X; Ran H; Liu H
Colloids Surf B Biointerfaces; 2023 Mar; 223():113157. PubMed ID: 36716658
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembled Copper-Based Nanoparticles for Glutathione Activated and Enzymatic Cascade-Enhanced Ferroptosis and Immunotherapy in Cancer Treatment.
Song WF; Zeng JY; Ji P; Han ZY; Sun YX; Zhang XZ
Small; 2023 Aug; 19(35):e2301148. PubMed ID: 37118853
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Tumor-Targeting Carbon Dots for Tumor Microenvironment Activated Ferroptosis and Immunotherapy in Cancer Treatment.
Bao Y; Li G; Li S; Zhang H; Wu X; Yan R; Wang Z; Guo C; Jin Y
ACS Appl Mater Interfaces; 2023 Nov; ():. PubMed ID: 38015563
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin remodels macrophage into an M1 phenotype
Li LG; Peng XC; Yu TT; Xu HZ; Han N; Yang XX; Li QR; Hu J; Liu B; Yang ZY; Xu X; Chen X; Wang MF; Li TF
Front Pharmacol; 2022; 13():949835. PubMed ID: 36034842
[TBL] [Abstract][Full Text] [Related]
17. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
18. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F
J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808
[TBL] [Abstract][Full Text] [Related]
19. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.
Liu T; Zhu C; Chen X; Guan G; Zou C; Shen S; Wu J; Wang Y; Lin Z; Chen L; Cheng P; Cheng W; Wu A
Neuro Oncol; 2022 Jul; 24(7):1113-1125. PubMed ID: 35148413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
